Phase III Trial of Everolimus in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from RECORD-1

OBJECTIVE: To assess the efficacy and safety of everolimus in Japanese patients with metastatic renal cell carcinoma. METHODS: A subgroup analysis of the pivotal Phase III, randomized, double-blind, placebo-controlled trial of everolimus 10 mg/day in patients with disease progression after treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukamoto, Taiji, Shinohara, Nobuo, Tsuchiya, Norihiko, Hamamoto, Yasuo, Maruoka, Masayuki, Fujimoto, Hiroyuki, Niwakawa, Masashi, Uemura, Hirotsugu, Usami, Michiyuki, Terai, Akito, Kanayama, Hiro-omi, Sumiyoshi, Yoshiteru, Eto, Masatoshi, Akaza, Hideyuki
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012894/
https://www.ncbi.nlm.nih.gov/pubmed/20965941
http://dx.doi.org/10.1093/jjco/hyq166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012894/
https://www.ncbi.nlm.nih.gov/pubmed/20965941
http://dx.doi.org/10.1093/jjco/hyq166

Ejemplares similares